In summary, our data demonstrate that silencing TXNIP in MM cells results in reduced growth and viability, alongside increased apoptosis and ROS levels, while TXNIP expression promotes the activation of various pathways related to MM survival, as confirmed by mechanistic studies, RNA-sequencing, and analysis of patient data. The gene discussed is TXNIP; the disease is Miyoshi myopathy.